Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / CRSP - AIM Trial Moves Ahead And Other News: The Good Bad And Ugly Of Biopharma

CRSP - AIM Trial Moves Ahead And Other News: The Good Bad And Ugly Of Biopharma

CRISPR Therapeutics AG
  • AIM ImmunoTech reports IRB go ahead for AMP-511 clinical trial.
  • Vir Biotechnology reports positive data for VIR-2482 influenza A treatment.
  • CRISPR Therapeutics reports positive CARBON trial for CD19+ B-cell malignancies.

For further details see:

AIM Trial Moves Ahead, And Other News: The Good, Bad And Ugly Of Biopharma
Stock Information
Company Name: CRISPR Therapeutics AG
Stock Symbol: CRSP
Market: NASDAQ
Website: crisprtx.com
Menu
CRSP CRSP Quote CRSP Short CRSP News CRSP Articles CRSP Message Board
Get CRSP Alerts

News, Short Squeeze, Breakout and More Instantly...